Sort   by:  
 Page size 
UnknownA randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis.
Not available
S-EPMC4755340 | biostudies-literature
UnknownLumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR.
Not available
S-EPMC4764353 | biostudies-literature
UnknownGenetic modifiers of liver disease in cystic fibrosis.
Not available
S-EPMC3711243 | biostudies-literature
Sort   by:  
 Page size